Catalyst Wire Dossier Catalyst Wire Dossier

ND0611

ND0611 · NeuroDerm Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ND0611, covering 2010-10-05 to 2011-12-06. Get the full timeline:

Most recent: Clinical Trial Update: A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients [Phase 1, Phase 2]

See pricing